News - UF Innovate

DNAtrix and Valo Therapeutics Enter into Strategic Partnership to Develop Peptide-Coated Oncolytic Viruses for Treating Cancer (PR Newswire)

UF startup DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix’s clinical stage viruses and Valo’s proprietary antigenic peptide...

Banyan Biomarkers Receives Contract by U.S. Department of Defense for Banyan BTI™ (BusinessWire)

UF startup Banyan Biomarkers, Inc., a pioneer in developing biomarkers for mild traumatic brain injury (TBI), has been awarded a contract by the U.S. Department...

Ophthotech Expands Gene Therapy Pipeline in Orphan Retinal Diseases with Exclusive Option for Novel Product Candidates to Treat Best Vitelliform Macular Dystrophy (Ophthotech)

Ophthotech Corporation announced that it has entered into an exclusive option agreement with the University of Pennsylvania (Penn) and the University of Florida Research Foundation...

Lasers May Aid Greening-Diseased Citrus Trees (Morning AgClips)

A University of Florida scientist hopes to improve on laser technology to enhance the efficiency of spray solutions aimed at restoring vitality to greening-affected citrus...

RTI Surgical to Acquire Paradigm Spine (Healio)

UF startup RTI Surgical Inc. announced it has entered into a definitive agreement with Paradigm Spine LLC to acquire all outstanding equity interest of Paradigm...

Breathtec Provides Update on FAIMS Breathalyzer Development Program (Globe Newswire)

UF startup Breathtec Biomedical Inc. is pleased to report on the development of its Breathtec Disease Detection Breathalyzer prototype (V3) based on the FAIMS (field...

Nash Pharmaceuticals Announces Positive Pre-Clinical Results Showing Lead Compound NP-160 Significantly Reduces NALFD Score and Fibrosis in Non-Alcoholic Fatty Liver Disease (Breathtec Biomedical)

Nash Pharmaceuticals Inc., a wholly owned subsidiary of UF startup Breathtec Biomedical Inc., is pleased to announce that its lead compound for non-alcoholic steatohepatitis (“NASH”)...

Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach (Globe Newswire)

UF startup Sun BioPharma, Inc., a clinical stage biopharmaceutical company specializing in disruptive therapeutics for pancreatic diseases, announced that it will present results of a...

ViewRay to Supply UK’s GenesisCare With Country’s First MRIdian Systems (DOTmed)

UF startup ViewRay Inc. is set to deliver the first of Great Britain’s MRIdian MR-guided radiotherapy systems as part of a new partnership between it...

OxThera Presents Encouraging 52-Week Efficacy and Safety Data for Oxabact® in Primary Hyperoxaluria Type 1 (PH1) Patients with ESRD (PR Newswire)

UF startup OxThera AB, a Stockholm-based privately-held biopharmaceutical company and leader in the field of microbiome derived biotherapeutics, announced a poster presentation showing encouraging Oxabact®...

UF News